Topical ofloxacin use in G6PD deficiency - safe or unsafe?

Abstract

we have recently treated a paediatric patient with known glucose-6-phosphate dehydrogenase (G6PD) deficiency and wished to communicate to the clinical ENT community the controversies around the use of fluoroquinolone (FQ) antibiotic drops in this patient cohort.

This article is protected by copyright. All rights reserved.

http://ift.tt/2AbfnR9